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Introduction: Calcific aortic stenosis (AS) is a prevalent and worrisome healthcare problem. Patients 
with symptomatic severe AS have an indication for aortic valve replacement. Indication for operation 
remains controversal in patients with isolate, asymptomatic severe AS. North American and Euro-
pean guidelines agree on a class I indication for operation in patients with a reduced left ventricular 
ejection fraction (<50%) but are inconsistent for patients with other disease or comorbid factors1. The 
natural history of aortic stenosis should be better quantified to improve understanding of benefits and 
harms of intervention vs conservative treatment2,3. Aim: searching for latest knowledge about ma-
nagement of asymptomatic, severe AS and identification of highest risk patients that will have benefit 
from early intervention. 
Materials and Metods: The meta-analysis of literature search 2370 observational studies with total of 
4075 patients comparing an early surgical treatment strategy with watchful waiting1. The primary end 
point was all-cause death during long-term follow-up. Meta-analysis was performed on the associati-
on of prognostic indicators with the composite of death or aortic valve intervention found in multiva-
riable models. 
Conclusion: The optimal management strategy for asymptomatic patients with severe aortic stenosis 
remains unclear. Data suggest that many patients with asymptomatic severe AS develop an indication 
for aortic valve intervention, and their deaths are mostly cardiac but not only sudden. Meta-analysis 
indicates that intervention was associated with a significant reduction in all-cause mortality during 
follow-up. Variables associated with mortality-related outcomes indicates that prognosis is signifi-
cantly worse if global longitudinal strain or valvulo-arterial impedance is present even with a preser-
ved LV function, if AS is more severe as measured by higher valve gradient and lower valve area, and if 
atherosclerotic risk factors, such as dyslipidemia or diabetes, are present. 
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